158 related articles for article (PubMed ID: 37449351)
1. Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial.
Jeong C; Ha J; Yoo JI; Lee YK; Kim JH; Ha YC; Min YK; Byun DW; Baek KH; Chung HY
J Bone Metab; 2023 May; 30(2):189-199. PubMed ID: 37449351
[TBL] [Abstract][Full Text] [Related]
2. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients.
Cho SK; Kim H; Lee J; Nam E; Lee S; Choi YY; Sung YK
Arthritis Res Ther; 2021 Jul; 23(1):176. PubMed ID: 34215316
[TBL] [Abstract][Full Text] [Related]
4. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
Miller PD; Chines AA; Christiansen C; Hoeck HC; Kendler DL; Lewiecki EM; Woodson G; Levine AB; Constantine G; Delmas PD
J Bone Miner Res; 2008 Apr; 23(4):525-35. PubMed ID: 18072873
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial.
Lee YB; Baek KH; Chung HY; Byun DW; Min YK
J Bone Metab; 2022 Aug; 29(3):155-163. PubMed ID: 36153851
[TBL] [Abstract][Full Text] [Related]
6. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
7. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
Välimäki MJ; Farrerons-Minguella J; Halse J; Kröger H; Maroni M; Mulder H; Muñoz-Torres M; Sääf M; Snorre Øfjord E
Clin Ther; 2007 Sep; 29(9):1937-49. PubMed ID: 18035193
[TBL] [Abstract][Full Text] [Related]
8. Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
Silverman SL; Chines AA; Kendler DL; Kung AW; Teglbjærg CS; Felsenberg D; Mairon N; Constantine GD; Adachi JD;
Osteoporos Int; 2012 Jan; 23(1):351-63. PubMed ID: 21779819
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bazedoxifene in postmenopausal Asian women.
Xu L; Tsai KS; Kim GS; Wu Y; Vincendon P; Chines AA; Constantine GD
Osteoporos Int; 2011 Feb; 22(2):559-65. PubMed ID: 20535607
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
11. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R
Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
[TBL] [Abstract][Full Text] [Related]
12. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial.
Vallibhakara SA; Nakpalat K; Sophonsritsuk A; Tantitham C; Vallibhakara O
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959779
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia.
Argyrou C; Karlafti E; Lampropoulou-Adamidou K; Tournis S; Makris K; Trovas G; Dontas I; Triantafyllopoulos IK
J Musculoskelet Neuronal Interact; 2020 Mar; 20(1):12-17. PubMed ID: 32131366
[TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
Drugs R D; 2008; 9(3):191-6. PubMed ID: 18457472
[TBL] [Abstract][Full Text] [Related]
15. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
16. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
17. The effect of short-term low-energy ultraviolet B irradiation on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis: a randomized single-blinded controlled clinical trial.
Micić I; Jeon IH; Park SH; Hwa SS; Chun JM; Stojiljković P
Srp Arh Celok Lek; 2013; 141(9-10):615-22. PubMed ID: 24364223
[TBL] [Abstract][Full Text] [Related]
18. A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture.
Palacios S; Silverman SL; de Villiers TJ; Levine AB; Goemaere S; Brown JP; De Cicco Nardone F; Williams R; Hines TL; Mirkin S; Chines AA;
Menopause; 2015 Aug; 22(8):806-13. PubMed ID: 25668306
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial.
de Villiers TJ; Chines AA; Palacios S; Lips P; Sawicki AZ; Levine AB; Codreanu C; Kelepouris N; Brown JP
Osteoporos Int; 2011 Feb; 22(2):567-76. PubMed ID: 20535606
[TBL] [Abstract][Full Text] [Related]
20. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]